An afternoon of talks from groups across the University of Oxford, including NDM, working at the fascinating interface between immunology and neuroscience to be held at the Richard Doll Building on 30 October 2017 13.00 to 18.00. Register here.
The inaugural MQPH 2018 Conference will take place at Keble College, Oxford from 23 – 28 September 2018, and will bring together people from a diversity of sectors. Registration opens February 2018 but you can pre-register your interest here.
Professor Xin Lu, Director of the Oxford branch of the Ludwig Institute for Cancer Research, identifies the switches that turn cell growth off and on, which would have profound implications for cancer medicine. If the right mechanisms can be found, cancer cells could be targeted specifically, resulting in more efficient treatments. Nuclear reprogramming could also enable cells to be utilized more safely and effectively in regenerative medicine.
Science Oxford's Young Scientists of the Year celebration, run in partnership with the Nuffield Department of Medicine and Rutherford Appleton Laboratory, honours some of the county’s brightest and hard-working A-level students. The 2017 celebration was held at the Museum of Natural History last Thursday and welcomed the students, their proud parents and teachers with a drinks and canapé reception. This was followed by a series of talks by inspiring scientists, including Professor Sarah Rowland-Jones.
A multi-disciplinary research team from the Universities of Oxford, MRC LMB, Liverpool, Cancer Research UK and pharma (Forma Therapeutics) has performed structural studies of USP7 inhibitor-enzyme interactions, demonstrating that ubiquitin-specific proteases (USPs) are tractable drug targets for cancer and also other diseases. Professor Benedikt Kessler and Dr Adan Pinto-Fernandez from Oxford’s Target Discovery Institute were part of this study.
In a recently published paper in The Lancet, Professor Peter Horby outlines potential epidemics in Africa. It is difficult to predict when and where new epidemics might occur so we can be better prepared and have a proactive response.
Thu 26 Oct 1-2pm
Lecture Theatre 1
Dr Jeffrey Aronson and Dr Ben Storey
Acute General Medicine Firm B: 'Fatal drug toxicity and genetic polymorphisms'
Renal: 'Mortality Trends of ESRD patients from Oxfordshire and all-England, 1967-2017',
Chair: Prof Chris Conlon